On August 24-26 in Rio de Janeiro, Brazil, GAfPA hosted the Latin American Biologics and Biosimilars Policy Advocacy Summit. The summit brought together the most prominent cross-disease patient advocacy leaders from Argentina, Brazil, Colombia, Central America, Chile, Uruguay, and Peru.
